Literature DB >> 33956149

Escherichia coli as a platform microbial host for systems metabolic engineering.

Dongsoo Yang1,2, Cindy Pricilia Surya Prabowo1, Hyunmin Eun1, Seon Young Park1,2, In Jin Cho1, Song Jiao1,2, Sang Yup Lee1,2,3.   

Abstract

Bio-based production of industrially important chemicals and materials from non-edible and renewable biomass has become increasingly important to resolve the urgent worldwide issues including climate change. Also, bio-based production, instead of chemical synthesis, of food ingredients and natural products has gained ever increasing interest for health benefits. Systems metabolic engineering allows more efficient development of microbial cell factories capable of sustainable, green, and human-friendly production of diverse chemicals and materials. Escherichia coli is unarguably the most widely employed host strain for the bio-based production of chemicals and materials. In the present paper, we review the tools and strategies employed for systems metabolic engineering of E. coli. Next, representative examples and strategies for the production of chemicals including biofuels, bulk and specialty chemicals, and natural products are discussed, followed by discussion on materials including polyhydroxyalkanoates (PHAs), proteins, and nanomaterials. Lastly, future perspectives and challenges remaining for systems metabolic engineering of E. coli are discussed.
© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  E. coli; industrial biotechnology; metabolic engineering; microbial cell factory

Mesh:

Substances:

Year:  2021        PMID: 33956149     DOI: 10.1042/EBC20200172

Source DB:  PubMed          Journal:  Essays Biochem        ISSN: 0071-1365            Impact factor:   8.000


  1 in total

Review 1.  Recent advances in microbial co-culture for production of value-added compounds.

Authors:  Nguyen Huy Thuan; Vinay Bharadwaj Tatipamula; Nguyen Xuan Canh; Nguyen Van Giang
Journal:  3 Biotech       Date:  2022-04-19       Impact factor: 2.893

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.